Coloplast A/S (OTCMKTS:CLPBY) Reaches New 52-Week Low – What’s Next?

Posted by Trevor Kearing on Feb 20th, 2026

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report)’s stock price hit a new 52-week low during trading on Wednesday . The company traded as low as $7.62 and last traded at $7.65, with a volume of 36598 shares. The stock had previously closed at $7.73.

Wall Street Analysts Forecast Growth

Separately, Sanford C. Bernstein upgraded shares of Coloplast A/S to a “hold” rating in a research report on Wednesday, January 28th. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Get Our Latest Stock Report on Coloplast A/S

Coloplast A/S Stock Up 1.5%

The company’s 50 day moving average is $8.40 and its 200 day moving average is $8.95. The company has a market cap of $17.22 billion, a PE ratio of 28.30, a P/E/G ratio of 0.75 and a beta of 0.26. The company has a current ratio of 1.30, a quick ratio of 1.00 and a debt-to-equity ratio of 1.50.

Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last issued its earnings results on Friday, February 6th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The business had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.12 billion. Coloplast A/S had a net margin of 14.35% and a return on equity of 27.87%. As a group, analysts predict that Coloplast A/S Sponsored ADR will post 0.31 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

(Get Free Report)

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.